GC Biopharma Ships First Doses of World's First Recombinant Anthrax Vaccine, 'BARYTHRAX inj.'

First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...

24/7 Market News- Kraig Labs Breakthrough Science is Pivoting to Scalable Business

DENVER, Dec. 10, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market ...

Peptide Therapeutics Market Size to Reach USD 82.19 Billion by 2032; Surging Requirements for Targeted Medicines in Oncology Augment Market Expansion - SNS Insider

According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...

Hamilton O. Smith, Who Made a Biotech Breakthrough, Is Dead at 94

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...
Nature

David Baltimore obituary: virologist whose enzyme discovery transformed understanding of cancer and HIV/AIDS

The protein, reverse transcriptase, has become an essential tool for making DNA copies of RNA.
Medindia

Saol Therapeutics Has Been Granted a Type A Meeting with the FDA to Determine the Path Forward for SL1009 in Pyruvate Dehydrogenase Complex Deficiency (PDCD)

FDA grants a Type A meeting on December 18th to review new and expanded datasets submitted by Saol to help identify a feasible path forward without the need for an additional clinical trial ROSWELL, ...

Woolworths-backed biotech All G raises $10m to create ‘bio-identical’ human breast milk

An Australian biotech firm says it has successfully used precision fermentation to reproduce the most vital proteins in human ...

Dyadic International, Inc. (DYAI) Presents at IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 Transcript

Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...
Tax Guru

Labour Codes Modernize Safety & Welfare Framework in Pharma Industry

The OSHWC Code, 2020 and Social Security Code enhance worker protection in pharma through risk management, medical ...
Medindia

Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US

Susan Ringdal EVP, Strategic Planning and Global Affairs +44 (0)20 7399 2760/ +44 7776 477050 Steven Weiss US Communications +1 732 788 8279 ...
The Manila Times

Solid Biosciences Receives FDA Rare Pediatric Disease Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia

SGT-212 has been granted FDA Rare Pediatric Disease and Fast Track designations - - SGT-212 is the only dual route gene therapy in development to treat Friedreich’s ataxia - CHARLESTOWN, Mass., Dec.
Stocktwits on MSN

Novartis Stock Rises Premarket After FDA Approves First Gene Therapy For Teens And Adults With Muscle-Weakening Disorder

FDA cleared Itvisma as the first gene-replacement therapy available to people 2 and older with the rare muscle-weakening condition. ・Phase III data showed improved or stabilized motor function with a ...